Rain Oncology Inc. Common Stock
RAIN
RAIN was delisted on the 25th of January, 2024.
0 hedge funds and large institutions have $0 invested in Rain Oncology Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 58 closing their positions.
46.42% less ownership
Funds ownership: 46.42% → 0% (-46%)
100% less funds holding
Funds holding: 58 → 0 (-58)
100% less capital invested
Capital invested by funds: $20.3M → $0 (-$20.3M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 58
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
-$4.62M |
| 2 |
BI
BVF Inc
San Francisco,
California
|
-$4.23M |
| 3 |
SB
Samsara BioCapital
Palo Alto,
California
|
-$2.44M |
| 4 |
BCM
BML Capital Management
Zionsville,
Indiana
|
-$1.62M |
| 5 |
BC
Boxer Capital
San Diego,
California
|
-$1.38M |
RAIN Hedge Fund Activity: Q1 2024 in Review
0 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Rain Oncology Inc. Common Stock (RAIN) for Q1 2024, worth a combined $0 — down 100% from $20.3M a quarter earlier.
Sellers outnumbered buyers: 58 funds closed out of RAIN and 0 opened new positions — a net loss of 58 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Tang Capital Management, exiting entirely with an estimated $4.62M sold.
- 0 institutional investors held Rain Oncology Inc. Common Stock (RAIN) as of Q1 2024, down from 58 in Q4 2023.
- Funds reported $0 of Rain Oncology Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
- 0 funds opened new Rain Oncology Inc. Common Stock positions in Q1 2024 and 58 closed out, a net change of -58 holders.
- The largest Rain Oncology Inc. Common Stock seller in Q1 2024 was Tang Capital Management, an estimated $4.62M sold.
Based on aggregated 13F filings for Q1 2024.